½ÃÀ庸°í¼­
»óǰÄÚµå
1589840

¼¼°èÀÇ ¾È°ú ¼ö¼ú ½ÃÀå : Á¦Ç°, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Eye Care Surgical Market by Product (Implants & Stents, Laser Surgery Devices, Phacoemulsification Equipment), Application (Cataract Surgery, Corneal Surgery, Glaucoma Surgery), End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 185 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¾È°ú ¼ö¼ú ½ÃÀåÀº 2023³â¿¡ 41¾ï 8,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 45¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 8.79%·Î ¼ºÀåÇϰí, 2030³â¿¡´Â 75¾ï 4,000¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾È°ú ¼ö¼ú ½ÃÀå¿¡´Â ´Ù¾çÇÑ ¾È°ú Áúȯ ¹× ½Ã·Â Àå¾Ö¸¦ Ä¡·áÇϱâ À§ÇÑ ¼ö¼ú, Àåºñ ¹× ±â¼úÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ºÐ¾ß´Â ¼¼°è Àα¸ÀÇ °í·ÉÈ­, ¹é³»Àå ¹× ³ì³»Àå°ú °°Àº ¾È ÁúȯÀÇ À¯º´·ü Áõ°¡ ¹× ±â¼ú Áøº¸¿¡ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¿ëµµ´Â Æø³Ð°Ô, ¶ó½Ä°ú °°Àº ±³Á¤ ¼ö¼úºÎÅÍ ¹é³»Àå Á¦°Å³ª ¸Á¸· ¼öº¹±îÁö ´Ù¾çÇÕ´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚ´Â ÁÖ·Î º´¿ø, ¾È°ú Àü¹® Ŭ¸®´Ð, ¿¬±¸ ±â°ü µîÀÔ´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ÆèÅäÃÊ ·¹ÀÌÀú¿Í ·Îº¿ Áö¿ø ¼ö¼ú µîÀÇ ±â¼ú Áøº¸, ´« °Ç°­¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö°í, ½Ã·Â ÄÉ¾î °³¼±¿¡ ÃÊÁ¡À» ¸ÂÃá Á¤ºÎÀÇ ´ëó µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí Áø´Ü°ú ¼ö¼ú¿¡¼­ ÀΰøÁö´ÉÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ È£±âÀÔ´Ï´Ù. ½ÅÈï ½ÃÀå, ƯÈ÷ ¾Æ½Ã¾ÆÅÂÆò¾ç°ú ¶óƾ¾Æ¸Þ¸®Ä«´Â ÇコÄɾî ÀÎÇÁ¶ó °³¼±°ú ÇコÄÉ¾î ±â¼ú ÅõÀÚ Áõ°¡·Î Å« È®´ë °¡´É¼ºÀ» °®°í ÀÖ½À´Ï´Ù. ±×·¯³ª °úÁ¦·Î´Â ¼³ºñ ºñ¿ëÀÇ »ó½Â, ¼÷·ÃµÈ ÀÎÀçÀÇ ºÎÁ·, ¾ö°ÝÇÑ ±ÔÁ¦ Á¤Ã¥ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ °æÀïÀÌ Ä¡¿­ÇØÁö°í ±Þ¼ÓÇÑ ±â¼ú Çõ½Å¿¡ ´ëÇÑ ¾Ð·ÂÀÌ ³ô¾ÆÁö±â ¶§¹®¿¡ °æ¿µ ÀÚ¿øÀÌ ¹Ú¹Ú ÇÒ °¡´É¼ºµµ ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀ» À§ÇÑ ÃÖÀûÀÇ ºÐ¾ß·Î´Â ħ½À¼ºÀÌ ³·Àº ¼ö¼ú ÀýÂ÷ÀÇ °³¹ß, ¿µ»ó Áø´Ü ½Ã½ºÅÛÀÇ °­È­, ¸ÂÃãÇü Ä¡·á ÇÁ·ÎÅäÄÝÀ» À§ÇÑ À¯ÀüÀÚ ÇÁ·ÎÆÄÀϸµÀ» ÀÌ¿ëÇÑ ¸ÂÃãÇü ÀÇ·á Á¢±Ù¹ý µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿ø°Ý ÀǷḦ ¼ö¼ú ÈÄ °ü¸®¿¡ ÅëÇÕÇÔÀ¸·Î½á ȯÀÚ °ü¸® ¹× ȸº¹ °úÁ¤À» °£¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °æÀïÀº Ä¡¿­ÇÏ°í ºü¸£°Ô ÁøÈ­Çϰí Àֱ⠶§¹®¿¡ Áö¼ÓÀûÀÎ Çõ½Å°ú ±ÔÁ¦ ÁöħÀ» ÁؼöÇØ¾ß ÇÕ´Ï´Ù. ±â¾÷Àº ¿¬±¸°³¹ßÀ» °­È­ÇÏ°í ±â¼ú·ÂÀ» È®´ëÇϱâ À§ÇØ Àü·«Àû ÆÄÆ®³Ê½Ê°ú ÇÕº´¿¡ ÁÖ·ÂÇØ¾ß ÇÕ´Ï´Ù. ±â¼ú °ÝÂ÷¸¦ ÇØ°áÇϱâ À§ÇÑ ±³À° ÇÁ·Î±×·¥¿¡ ´ëÇÑ ÅõÀÚ¿Í ±ÔÁ¦ Áؼö¸¦ ¿ëÀÌÇÏ°Ô Çϱâ À§ÇØ Á¤ºÎ ±â°ü°úÀÇ Çù·ÂÀº ¾÷¹« È¿À²¼ºÀ» ´õ¿í ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 41¾ï 8,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 45¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 75¾ï 4,000¸¸ ´Þ·¯
CAGR(%) 8.79%

½ÃÀå ¿ªÇÐ: ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ¾È°ú ¼ö¼ú ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¾È°ú ¼ö¼ú ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ëÀ̳ª ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¼°èÀÇ ¾ÈÁúȯ À¯º´·üÀÇ »ó½Â
    • ¾È°ú ¼ö¼ú ±â±¸ÀÇ ±â¼úÀû Áøº¸
    • ½Ã°¢Àå¾Ö¸¦ ÅëÁ¦Çϱâ À§ÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¼ö¼ú±â±¸ÀÇ °íºñ¿ë°ú ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·
  • ½ÃÀå ±âȸ
    • ÷´Ü Á¦Ç°°ú ±â¼ú °³¹ß Áõ°¡
    • ½ÅÈï±¹ÀÇ ÀÇ·á½Ã¼³ Áõ°¡
  • ½ÃÀåÀÇ °úÁ¦
    • Àú¼Òµæ °æÁ¦±Ç¿¡¼­ ¾È°ú ÀÇ·á¿¡ ´ëÇÑ ÀÎ½Ä ºÎÁ·°ú Á¢±Ù¼ºÀÇ ³·À½

Portre's Five Forces: ¾È°ú ¼ö¼ú ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂûÀ» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¾È°ú ¼ö¼ú ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ãȯ°æ ¿äÀÎÀº ¾È°ú ¼ö¼ú ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¾È°ú ¼ö¼ú ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

¾È°ú ¼ö¼ú ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¾È°ú ¼ö¼ú ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¾È°ú ¼ö¼ú ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Á¤º¸¸¦ ±â¹ÝÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ¾È°ú ¼ö¼ú ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

¾È°ú ¼ö¼ú ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ ¹æ¹ýÀ» »ç¿ëÇÏ¸é °æÀï ±¸µµ¿¡¼­ ¾î·Á¿òÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ µµ¿òÀÌ µÇ´Â Áß¿äÇÑ Áú¹®¿¡ ÀÀ´äÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¼¼°è ¾È±¸ ÁúȯÀÇ ÀÌȯÀ²ÀÌ »ó½Â
      • ¾È°ú ¼ö¼ú ±â±¸ÀÇ ±â¼úÀû Áøº¸
      • ½Ã°¢Àå¾Ö¸¦ ¾ïÁ¦Çϱâ À§ÇÑ Á¤ºÎÀÇ ´ëó °­È­
    • ¾ïÁ¦¿äÀÎ
      • ¼ö¼ú±â±¸ÀÇ °íºñ¿ë°ú ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·
    • ±âȸ
      • ÷´Ü Á¦Ç°°ú ±â¼ú °³¹ß Áõ°¡
      • ½ÅÈï±¹¿¡¼­ÀÇ ÀÇ·á½Ã¼³ Áõ°¡
    • °úÁ¦
      • Àú¼Òµæ ±¹°¡¿¡¼­ ¾È°ú ÀÇ·á¿¡ ´ëÇÑ ÀÎÁöµµ ºÎÁ·°ú Á¢±Ù ºÒ·®
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ¾È°ú ¼ö¼ú ½ÃÀå : Á¦Ç°º°

  • ÀÓÇöõÆ®¿Í ½ºÅÙÆ®
  • ·¹ÀÌÀú ¼ö¼ú ÀåÄ¡
  • ÃÊÀ½ÆÄ À¯È­ ÈíÀÔ ÀåÄ¡
  • Á¡Åº¼º ¹°Áú

Á¦7Àå ¾È°ú ¼ö¼ú ½ÃÀå : ¿ëµµº°

  • ¹é³»Àå ¼ö¼ú
  • °¢¸· ¼ö¼ú
  • ³ì³»Àå ¼ö¼ú
  • ´« Çü¼º ¼ö¼ú
  • ±¼Àý ±³Á¤ ¼ö¼ú
  • À¯¸®Ã¼ ¸Á¸· ¼ö¼ú

Á¦8Àå ¾È°ú ¼ö¼ú ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ¾È°ú Á¶»ç ±â°ü
  • º´¿ø
  • ¾È°ú Ŭ¸®´Ð

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ¾È°ú ¼ö¼ú ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¾È°ú ¼ö¼ú ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¾È°ú ¼ö¼ú ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Bausch & Lomb Incorporated
  • BVI Holdings Limited
  • Essilor International SA
  • Glaukos Corporation
  • iSTAR Medical
  • Johnson & Johnson Services, Inc.
  • Lumenis Be Ltd.
  • Millennium Surgical Corp
  • NIDEK CO., LTD.
  • Novartis AG
  • RetinAI Medical AG
  • Sensimed AG
  • Sight Sciences, Inc.
  • Surgical Holdings
  • Topcon Corporation
JHS 24.11.21

The Eye Care Surgical Market was valued at USD 4.18 billion in 2023, expected to reach USD 4.54 billion in 2024, and is projected to grow at a CAGR of 8.79%, to USD 7.54 billion by 2030.

The Eye Care Surgical market encompasses surgical procedures, equipment, and technologies designed to treat various ocular conditions and vision impairment issues. This sector is vital due to an aging global population, rising prevalence of eye conditions like cataracts and glaucoma, and technological advancements. The applications are broad, ranging from corrective surgeries like LASIK to cataract removal and retinal repair. End-users primarily include hospitals, specialized eye clinics, and research institutions. Key growth influencers include technological advancements such as femtosecond lasers and robotic-assisted surgeries, increasing awareness about eye health, and government initiatives focused on vision care improvement. Opportunities arise from the growing demand for minimally invasive procedures and the increasing adoption of artificial intelligence in diagnostics and surgery. Emerging markets, particularly in Asia-Pacific and Latin America, present significant expansion potential due to improving healthcare infrastructure and increasing investment in healthcare technologies. However, challenges include high equipment costs, skilled personnel shortages, and stringent regulatory policies. There is also growing competition and pressure to innovate rapidly, which can strain resources. The best areas for innovation include developing less invasive surgical techniques, enhanced imaging systems, and personalized medicine approaches using genetic profiling for tailored treatment protocols. Additionally, integrating telemedicine into post-operative care could streamline patient management and recovery processes. The market nature is competitive and rapidly evolving, necessitating continuous innovation and adherence to regulatory guidelines. Companies should focus on strategic partnerships and mergers to bolster research & development efforts and expand technological capabilities. Investing in training programs to address the skill gap and collaborating with governmental bodies to ease compliance with regulations can further enhance operational efficiencies.

KEY MARKET STATISTICS
Base Year [2023] USD 4.18 billion
Estimated Year [2024] USD 4.54 billion
Forecast Year [2030] USD 7.54 billion
CAGR (%) 8.79%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Eye Care Surgical Market

The Eye Care Surgical Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of eye diseases worldwide
    • Technological advancements in eye surgical instruments
    • Increasing government initiatives to control visual impairment
  • Market Restraints
    • High cost of surgical instruments and lack of skilled professional
  • Market Opportunities
    • Rising development of advanced products and technologies
    • Increasing healthcare facilities in the emerging economies
  • Market Challenges
    • Lack of awareness and low accessibility to eye care in low-income economies

Porter's Five Forces: A Strategic Tool for Navigating the Eye Care Surgical Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Eye Care Surgical Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Eye Care Surgical Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Eye Care Surgical Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Eye Care Surgical Market

A detailed market share analysis in the Eye Care Surgical Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Eye Care Surgical Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Eye Care Surgical Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Eye Care Surgical Market

A strategic analysis of the Eye Care Surgical Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Eye Care Surgical Market, highlighting leading vendors and their innovative profiles. These include Bausch & Lomb Incorporated, BVI Holdings Limited, Essilor International S.A., Glaukos Corporation, iSTAR Medical, Johnson & Johnson Services, Inc., Lumenis Be Ltd., Millennium Surgical Corp, NIDEK CO., LTD., Novartis AG, RetinAI Medical AG, Sensimed AG, Sight Sciences, Inc., Surgical Holdings, and Topcon Corporation.

Market Segmentation & Coverage

This research report categorizes the Eye Care Surgical Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Implants & Stents, Laser Surgery Devices, Phacoemulsification Equipment, and Viscoelastics.
  • Based on Application, market is studied across Cataract Surgery, Corneal Surgery, Glaucoma Surgery, Oculoplastic Surgery, Refractive Surgery, and Vitreo-retinal Surgery.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Eye Research Institutes, Hospitals, and Ophthalmology Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of eye diseases worldwide
      • 5.1.1.2. Technological advancements in eye surgical instruments
      • 5.1.1.3. Increasing government initiatives to control visual impairment
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of surgical instruments and lack of skilled professional
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising development of advanced products and technologies
      • 5.1.3.2. Increasing healthcare facilities in the emerging economies
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness and low accessibility to eye care in low-income economies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Eye Care Surgical Market, by Product

  • 6.1. Introduction
  • 6.2. Implants & Stents
  • 6.3. Laser Surgery Devices
  • 6.4. Phacoemulsification Equipment
  • 6.5. Viscoelastics

7. Eye Care Surgical Market, by Application

  • 7.1. Introduction
  • 7.2. Cataract Surgery
  • 7.3. Corneal Surgery
  • 7.4. Glaucoma Surgery
  • 7.5. Oculoplastic Surgery
  • 7.6. Refractive Surgery
  • 7.7. Vitreo-retinal Surgery

8. Eye Care Surgical Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Eye Research Institutes
  • 8.4. Hospitals
  • 8.5. Ophthalmology Clinics

9. Americas Eye Care Surgical Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Eye Care Surgical Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Eye Care Surgical Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bausch & Lomb Incorporated
  • 2. BVI Holdings Limited
  • 3. Essilor International S.A.
  • 4. Glaukos Corporation
  • 5. iSTAR Medical
  • 6. Johnson & Johnson Services, Inc.
  • 7. Lumenis Be Ltd.
  • 8. Millennium Surgical Corp
  • 9. NIDEK CO., LTD.
  • 10. Novartis AG
  • 11. RetinAI Medical AG
  • 12. Sensimed AG
  • 13. Sight Sciences, Inc.
  • 14. Surgical Holdings
  • 15. Topcon Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦